Copyright
©2014 Baishideng Publishing Group Inc.
World J Diabetes. Jun 15, 2014; 5(3): 258-266
Published online Jun 15, 2014. doi: 10.4239/wjd.v5.i3.258
Published online Jun 15, 2014. doi: 10.4239/wjd.v5.i3.258
Study | Model | Diabetic drug | Effect |
Animal studies | |||
Gross et al[23], 1992 | Dogs | Glibenclamide (glyburide) | Abolished |
Toombs et al[50], 1993 | Rabbits | Glibenclamide | Abolished |
Mocanu et al[47], 2001 | Rats | Glimepiride | Preserved |
Maddock et al[51], 2004 | Rats | Glibenclamide | Abolished |
Glimepiride | Preserved | ||
Hausenloy et al[61], 2013 | Rats | Glimepiride | Preserved |
Ye et al[62], 2008 | Rats | Pioglitazone | Preserved |
Glibenclamide (glyburide) | Abolished | ||
Glimepiride | Preserved | ||
Horimoto et al[63], 2002 | Rabbits | Glibenclamide | Abolished |
Glimepiride | Preserved | ||
Bose et al[69], 2005 | Rats | Native sequenced human GLP-1 | Preserved |
Zhu et al[73], 2011 | Rats | Pioglitazone | IPC mimic |
Sasaki et al[74], 2007 | Rats | Pioglitazone | IPC mimic |
Ahmed et al[75], 2011 | Rats | Pioglitazone | IPC mimic |
Li et al[76], 2008 | Rats | Pioglitazone | Preserved |
Wynne et al[77], 2005 | Rats | Pioglitazone | IPC mimic |
Sarraf et al[78], 2012 | Porcine | Pioglitazone | Abolished |
Rosiglitazone | Abolished | ||
Human studies | |||
Cleveland et al[52], 1997 | Atrial muscle trabeculae | Glibenclamide (glyburide) | Abolished |
Tomai et al[53], 1994 | Human | Glibenclamide | Abolished |
Klepzig et al[45], 1999 | Human | Glibenclamide | Abolished |
Glimepiride | Preserved | ||
Lee et al[54], 2002 | Human | Glibenclamide | Abolished |
Tomai et al[55], 1999 | Human | Glibenclamide | Abolished |
Ovünç[56], 2000 | Human | Glibenclamide | Abolished |
Ferreira et al[57], 2005 | Human | Glibenclamide | Abolished |
Bilinska et al[58], 2007 | Human | Glibenclamide | Abolished |
Gliclazide | Partially preserved | ||
Bogaty et al[59], 1998 | Human | Glibenclamide | Preserved |
Correa et al[60], 1997 | Human | Glibenclamide | Preserved |
Loubani et al[64], 2005 | Right atrial appendages | Glibenclamide | Abolished |
Gliclazide | Preserved (but abolished in supratherapeutic concentrations) | ||
Hueb et al[66], 2007 | Human | Repaglinide | Abolished |
Rahmi et al[70], 2013 | Human | Repaglinide | Abolished |
Vildagliptin | Preserved |
- Citation: Rahmi Garcia RM, Rezende PC, Hueb W. Impact of hypoglycemic agents on myocardial ischemic preconditioning. World J Diabetes 2014; 5(3): 258-266
- URL: https://www.wjgnet.com/1948-9358/full/v5/i3/258.htm
- DOI: https://dx.doi.org/10.4239/wjd.v5.i3.258